Population pharmacokinetics of magnesium in preeclampsia
- 1 September 2001
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 185 (3) , 593-599
- https://doi.org/10.1067/mob.2001.116726
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Fundamentals of Population Modelling Opportunities for Hospital Pharmacy PracticeThe Australian Journal of Hospital Pharmacy, 1999
- Population PharmacokineticsClinical Pharmacokinetics, 1999
- Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity*Clinical Pharmacology & Therapeutics, 1997
- Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia TrialThe Lancet, 1995
- Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986American Journal of Obstetrics and Gynecology, 1990
- Magnesium sulfate is the ideal anticonvulsant inpreeclampsia-eclampsiaAmerican Journal of Obstetrics and Gynecology, 1990
- Measurement of magnesium in serum and urine with a random access analyzer by use of a modified xylidyl blue-1 procedureClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Spectrophotometric Determination of Magnesium with Sodium 1-Azo-2-hydroxy-3-(2,4-dimethylcarboxanilido)-naphthalene-1´-(2-hydroxybenzene-5-sulfonate)Analytical Chemistry, 1956
- A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsiaAmerican Journal of Obstetrics and Gynecology, 1925